Patient Guide: Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 14 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05299125
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Non-small Cell Lung Cancers
Phase: PHASE2

Where You Can Participate

This study is available at 14 locations across the country.

Top locations include:
  • • Fortaleza, Ceará
  • • Cachoeiro de Itapemirim, Espírito Santo
  • • Curitiba, Paraná
  • • And 11 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations - Join Clinical Trial NCTNCT05299125

How to Join This Clinical Trial - NCTNCT05299125

Learn how to participate in this PHASE2 trial studying an investigational therapy for Metastatic Non-small Cell Lung Cancers. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Non-small Cell Lung Cancers. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Non-small Cell Lung Cancers
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05299125 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 14 locations. Find a study site near you:

Clinical Research Site

Fortaleza, Ceará 60810-180 - Brazil

Status: Contact for availability

Clinical Research Site

Cachoeiro de Itapemirim, Espírito Santo 29308-065 - Brazil

Status: Contact for availability

Clinical Research Site

Curitiba, Paraná 81520-060 - Brazil

Status: Contact for availability

Clinical Research Site

Natal, Rio Grande do Norte 59062-000 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande do Sul 90050-170 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande do Sul 91751-443 - Brazil

Status: Contact for availability

Clinical Research Site

Barretos, São Paulo 14784400 - Brazil

Status: Contact for availability

Clinical Research Site

Ribeirão Preto, São Paulo 14015-010 - Brazil

Status: Contact for availability

Clinical Research Site

São José do Rio Preto, São Paulo 15090-000 - Brazil

Status: Contact for availability

Clinical Research Site

Rio de Janeiro, 20230-130 - Brazil

Status: Contact for availability

And 4 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Metastatic Non-small Cell Lung Cancers:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships